- Home
- / Autifony Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Autifony Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Total Funding
$24.2 M
Revenue
£22.8 M
FY, 2018
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.1M | 1.6M | 559.1K | 22.8M | ||||
| Operating expense total | 7.0M | 7.4M | 3.6M | 6.6M | ||||
| EBITDA | (503.3K) | (2.2M) | (4.0M) | (5.7M) | (5.7M) | (3.0M) | 16.4M | |
| EBITDA margin, % | -510.4% | -367.4% | -536.0% | 71.7% | ||||
| EBIT | (513.4K) | (2.3M) | (4.0M) | (3.8M) | (5.9M) | (5.8M) | (3.1M) | 16.2M |
| EBIT margin, % | -520.5% | -373.5% | -551.7% | 70.9% | ||||
| Pre tax profit | (512.9K) | (2.3M) | (4.0M) | (3.8M) | (5.8M) | (5.8M) | (3.1M) | 16.2M |
| Income tax expense | 330.1K | 545.5K | 575.9K | 821.7K | 1.4M | 37.1K | ||
| Net Income | (512.9K) | (2.3M) | (3.7M) | (3.3M) | (5.3M) | (5.0M) | (1.7M) | 16.2M |